跳至主要内容
临床试验/NCT02105909
NCT02105909已完成不适用

Genome Wide Association Studies (GWAS) to Identify Candidate Obesity Susceptibility Genes in a Carefully Phenotyped, Metabolically Healthy Population of Obese White Adults

University of Nevada, Las Vegas0 个研究点目标入组 81 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
81
主要终点
number of SNPs associated with high BMI

研究概览

简要总结

This is a GWAS pilot study that aims to identified possible candidate genes associate to obesity by exploring single nucleotide polymorphism (SNP) in a small group of obese , metabolically healthy white adults, matched with lean, white adults , metabolically healthy. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with obesity (as defined by BMI).

详细描述

Between 60%-70% of the risk of obesity appears to be heritable. Unfortunately, the exact genes involved have been difficult to identify. New technologies now exist to help researchers discover obesity susceptibility genes. One of these technologies is the Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) Array 6.0 chips. SNPs are individual base pair differences in genes of different individuals, and they are the main source of human genetic diversity. The "chips" are thumbnail-size silicon surfaces that contain copies of hundreds of thousands of SNPs of the human genome (in this case around 900,000). SNP chips allow researchers to screen thousands of genes in a single experiment and compare genes of subjects with a particular disease or condition with unaffected control subjects. The investigators study utilizes SNP chips to compare the genetic profiles of obese subjects (N = 20, body mass index > 35 kg/m2) without common obesity-related co-morbidities such as diabetes mellitus or hypertension with well matched, lean controls (N = 20, body mass index 18-25 kg/m2). This is a pilot study intended to explore the following: 1) possible associations between obesity and previously unidentified obesity susceptibility genes; 2) associations between known obesity genes and obesity risk in subjects without obesity-related metabolic co-morbidities; and 3) how well our genetic data conform to other studies in similar populations as a way of assessing if the investigators have identified a representative cohort of obese subjects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Adults 40 year old or older
  • Caucasian males or females
  • BMI ≥ 35 kg/m² or history of BMI ≥ 35 kg/m², or BMi less than 25 kg/m2
  • No current or past use of glucose lowering drugs
  • No current or past medical history of diabetes mellitus
  • No current or past medical history of established coronary artery disease (angina, myocardial infraction, abnormal cardiac stress test)
  • No current or past medical history of or treatment for thyroid disorders
  • No current or past use of lipid lowering drugs or diagnosis of a lipid disorder
  • No current or past medical history of or treatment for hypertension
  • Subject's willingness to provide the study investigators with a copy of their medical records or give permission to the study investigators to access the following specific medical information:
  • Fasting plasma glucose (less than 100 mg/dL/5.6 mmol/L)
  • HDL-C cholesterol (more than 40 mg/dL /1.03 mmol/L)
  • Total cholesterol (less than 239 mg/dL/ 6.18mmol/L)
  • LDL cholesterol (less than 159 mg/dL/4.11 mmol/L)

排除标准

  • - Known monogenic forms of obesity
  • Polycystic ovary disease (in women)
  • Malabsorptive or maldigestive syndromes (Celiac disease, Crohn's Disease, inflammatory bowel disease, etc.)
  • Anorexia nervosa or bulimia

结局指标

主要结局

number of SNPs associated with high BMI

时间窗: baseline

Using GWAS to identify candidate genes associate with obesity (high BMI) in a carefully phenotyped white adults with obesity (as defined by BMI), metabolically healthy, matched with lean, white adults metabolically healthy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doina Kulick, MD

Associate Professor of Medicine

University of Nevada, Reno

相似试验